I don't think anyone knows.
The one-month or so gap produces terrific efficacy results, so why test further would have been the pharmaceutical companies reaction, I presume, but whether those rates then reduce or remain stable if the follow up is delayed is, I believe, pretty much unknown.
The one-month or so gap produces terrific efficacy results, so why test further would have been the pharmaceutical companies reaction, I presume, but whether those rates then reduce or remain stable if the follow up is delayed is, I believe, pretty much unknown.
Comment